10q10k10q10k.net

vs

Side-by-side financial comparison of CREDIT ACCEPTANCE CORP (CACC) and CME Group (CME), based on the latest 10-Q / 10-K filings. Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.6B vs $579.9M, roughly 2.8× CREDIT ACCEPTANCE CORP). CME Group runs the higher net margin — 21.0% vs 71.7%, a 50.7% gap on every dollar of revenue. On growth, CME Group posted the faster year-over-year revenue change (8.1% vs 2.5%). CME Group produced more free cash flow last quarter ($1.1B vs $268.9M). Over the past eight quarters, CREDIT ACCEPTANCE CORP's revenue compounded faster (6.8% CAGR vs 5.3%).

Credit Acceptance Corporation is an auto finance company providing automobile loans and other related financial products. The company operates its financial program through a national network of dealer-partners, the automobile dealers participating in the programs. The company operates two programs: the "Portfolio Program" and the "Purchase Program". Through these programs, the company can advance money to automobile dealers in exchange for the right to service the underlying consumer loans a...

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

CACC vs CME — Head-to-Head

Bigger by revenue
CME
CME
2.8× larger
CME
$1.6B
$579.9M
CACC
Growing faster (revenue YoY)
CME
CME
+5.6% gap
CME
8.1%
2.5%
CACC
Higher net margin
CME
CME
50.7% more per $
CME
71.7%
21.0%
CACC
More free cash flow
CME
CME
$832.5M more FCF
CME
$1.1B
$268.9M
CACC
Faster 2-yr revenue CAGR
CACC
CACC
Annualised
CACC
6.8%
5.3%
CME

Income Statement — Q4 2025 vs Q4 2025

Metric
CACC
CACC
CME
CME
Revenue
$579.9M
$1.6B
Net Profit
$122.0M
$1.2B
Gross Margin
Operating Margin
27.1%
61.8%
Net Margin
21.0%
71.7%
Revenue YoY
2.5%
8.1%
Net Profit YoY
-19.7%
35.3%
EPS (diluted)
$10.87
$3.24

Green = leading value per metric. Periods may differ when fiscal calendars don't align — see 8-quarter trend below.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history — bar widths are scaled to the larger of the two companies so you can eyeball the size gap and growth trajectory without doing math. Quarters aligned by calendar period (report date) so offset fiscal years line up.

Revenue
CACC
CACC
CME
CME
Q4 25
$579.9M
$1.6B
Q3 25
$582.4M
$1.5B
Q2 25
$583.8M
$1.7B
Q1 25
$571.1M
$1.6B
Q4 24
$565.9M
$1.5B
Q3 24
$550.3M
$1.6B
Q2 24
$538.2M
$1.5B
Q1 24
$508.0M
$1.5B
Net Profit
CACC
CACC
CME
CME
Q4 25
$122.0M
$1.2B
Q3 25
$108.2M
$908.0M
Q2 25
$87.4M
$1.0B
Q1 25
$106.3M
$956.2M
Q4 24
$151.9M
$874.6M
Q3 24
$78.8M
$912.8M
Q2 24
$-47.1M
$883.2M
Q1 24
$64.3M
$855.2M
Operating Margin
CACC
CACC
CME
CME
Q4 25
27.1%
61.8%
Q3 25
25.6%
63.3%
Q2 25
20.2%
66.7%
Q1 25
24.8%
67.5%
Q4 24
33.9%
62.1%
Q3 24
19.4%
64.6%
Q2 24
-10.3%
65.3%
Q1 24
17.0%
64.5%
Net Margin
CACC
CACC
CME
CME
Q4 25
21.0%
71.7%
Q3 25
18.6%
59.1%
Q2 25
15.0%
60.6%
Q1 25
18.6%
58.2%
Q4 24
26.8%
57.3%
Q3 24
14.3%
57.6%
Q2 24
-8.8%
57.6%
Q1 24
12.7%
57.5%
EPS (diluted)
CACC
CACC
CME
CME
Q4 25
$10.87
$3.24
Q3 25
$9.43
$2.49
Q2 25
$7.42
$2.81
Q1 25
$8.66
$2.62
Q4 24
$12.28
$2.40
Q3 24
$6.35
$2.50
Q2 24
$-3.83
$2.42
Q1 24
$5.08
$2.35

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest filing — the kind of financial-strength check premium terminals charge for.

Metric
CACC
CACC
CME
CME
Cash + ST InvestmentsLiquidity on hand
$22.8M
$4.5B
Total DebtLower is stronger
Stockholders' EquityBook value
$1.5B
$28.7B
Total Assets
$8.6B
$198.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Cash + ST Investments
CACC
CACC
CME
CME
Q4 25
$22.8M
$4.5B
Q3 25
$15.9M
$2.6B
Q2 25
$70.0M
$2.1B
Q1 25
$528.8M
$1.5B
Q4 24
$343.7M
$3.0B
Q3 24
$159.7M
$2.4B
Q2 24
$8.3M
$1.9B
Q1 24
$8.4M
$1.6B
Stockholders' Equity
CACC
CACC
CME
CME
Q4 25
$1.5B
$28.7B
Q3 25
$1.6B
$28.2B
Q2 25
$1.6B
$27.7B
Q1 25
$1.7B
$27.0B
Q4 24
$1.7B
$26.5B
Q3 24
$1.6B
$28.2B
Q2 24
$1.6B
$27.6B
Q1 24
$1.7B
$27.2B
Total Assets
CACC
CACC
CME
CME
Q4 25
$8.6B
$198.4B
Q3 25
$8.6B
$187.1B
Q2 25
$8.7B
$179.9B
Q1 25
$9.3B
$157.8B
Q4 24
$8.9B
$137.4B
Q3 24
$8.7B
$137.8B
Q2 24
$8.3B
$123.4B
Q1 24
$8.1B
$132.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Net income can be massaged; cash flow is harder to fake.

Metric
CACC
CACC
CME
CME
Operating Cash FlowLast quarter
$269.3M
$1.1B
Free Cash FlowOCF − Capex
$268.9M
$1.1B
FCF MarginFCF / Revenue
46.4%
66.8%
Capex IntensityCapex / Revenue; lower = less reinvestment burden
0.1%
2.0%
Cash ConversionOCF / Net Profit; >1× = earnings back up with cash
2.21×
0.96×
TTM Free Cash FlowTrailing 4 quarters
$1.1B
$4.2B

8-quarter trend — quarters aligned by calendar period so offset fiscal years match up.

Operating Cash Flow
CACC
CACC
CME
CME
Q4 25
$269.3M
$1.1B
Q3 25
$299.4M
$968.1M
Q2 25
$139.7M
$1.1B
Q1 25
$346.2M
$1.1B
Q4 24
$306.2M
$1.0B
Q3 24
$317.7M
$1.0B
Q2 24
$204.0M
$776.9M
Q1 24
$310.0M
$892.7M
Free Cash Flow
CACC
CACC
CME
CME
Q4 25
$268.9M
$1.1B
Q3 25
$298.8M
$949.7M
Q2 25
$139.4M
$1.0B
Q1 25
$345.9M
$1.1B
Q4 24
$305.5M
$991.7M
Q3 24
$317.3M
$973.2M
Q2 24
$203.6M
$758.7M
Q1 24
$309.7M
$872.9M
FCF Margin
CACC
CACC
CME
CME
Q4 25
46.4%
66.8%
Q3 25
51.3%
61.8%
Q2 25
23.9%
61.5%
Q1 25
60.6%
67.1%
Q4 24
54.0%
65.0%
Q3 24
57.7%
61.4%
Q2 24
37.8%
49.5%
Q1 24
61.0%
58.7%
Capex Intensity
CACC
CACC
CME
CME
Q4 25
0.1%
2.0%
Q3 25
0.1%
1.2%
Q2 25
0.1%
1.1%
Q1 25
0.1%
0.9%
Q4 24
0.1%
1.7%
Q3 24
0.1%
1.9%
Q2 24
0.1%
1.2%
Q1 24
0.1%
1.3%
Cash Conversion
CACC
CACC
CME
CME
Q4 25
2.21×
0.96×
Q3 25
2.77×
1.07×
Q2 25
1.60×
1.03×
Q1 25
3.26×
1.17×
Q4 24
2.02×
1.16×
Q3 24
4.03×
1.10×
Q2 24
0.88×
Q1 24
4.82×
1.04×

Financial Flow Comparison

Sankey diagram of revenue → gross profit → operating profit → net profit for each company. Charts shown full-width and stacked so both segment hierarchies are readable side-by-side on desktop and mobile.

Revenue Breakdown by Segment

CACC
CACC

Segment breakdown not available.

CME
CME

Clearingandtransactionfees$1.3B81%
Market Data$208.0M13%
Other Revenue$112.8M7%
Onetimechargesandmiscellaneousrevenues$5.9M0%

Related Comparisons